Researchers have linked difficulty understanding speech in noisy environments with evidence of cochlear synaptopathy, or “hidden hearing loss,” in college students with normal hearing sensitivity.
Read More
Cilcare’s SAIPHIE project has been selected for the “i-Démo” call for projects under the France 2030 plan, aiming to leverage their expertise to address synaptopathy
Read More
Cilcare granted the pharmaceutical company rights to license two promising drug candidates for hearing disorders.
Read More
Cilcare has appointed a new chief medical officer to oversee clinical development strategies and collaborations, leveraging his extensive experience in medical affairs and pharmaceutical industry leadership.
Read More
Musician earplugs and hearing health education can benefit professionals in other industries, like dentistry, who suffer from hearing loss.
Read More
This article explores the foundation of ACT, Spectro-Temporal Modulation (STM), and how ACT compares to traditional speech-in-noise tests.
Read More
A new study shows that individuals who report tinnitus are experiencing auditory nerve loss not picked up by conventional hearing tests.
Read More
Biotech company CILcare adds four hearing experts to its Scientific Advisory Board: Keith Darrow, Stéphane Maison, Aimo Kannt, and Dona Jayakody. The SAB will help develop CILcare’s synaptopathy pipeline, which targets early markers of neurocognitive and inflammatory diseases.
Read More
Charles Liberman, in August of 2022, lead a team of researchers at the Mass Eye and Ear, where the team was awarded a second, five-year, $12.5 million P50 Clinical Research grant to continue their research on cochlear synaptopathy.
Read More
The award is reportedly one of the highest honors given in hearing science and was presented to Dr Liberman in a ceremony in Paris, France, on October 20, 2022. The Scientific Grand Prize carries a €100,000 (USD $98K) honorarium.
Read More
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage that was reportedly first discovered, according to an announcement from Mass Eye & Ear.
Read More
Gabriel Corfas, PhD, who serves as the director of Michigan Medicine’s Kresge Hearing Research Institute, says that one of the first events in “cochlear aging” that leads to hearing loss is the breakdown of synapses between inner hair cells, or IHCs, and spiral ganglion neurons, or SGNs.
Read More
Approximately 55 million people (globally) have acquired dementia and that number is expected to triple in the next 28 years (by 2050). Despite disappointment regarding the pharmacologic treatment of Alzheimer’s disease (there are as-of-yet no drugs which cure or reverse Alzheimer’s Disease, when cognitive disorders are screened, diagnosed, and managed early, the opportunity to positively alter the trajectory of cognitive decline increases. In this article, we’ll examine some lesser-known factors and recent peer-reviewed findings which may impact our understanding of the relationship between cognition and audition.
Read More
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders (NIDCD) of the National Institutes of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage first discovered at Mass Eye and Ear in 2009.
Read More
When a COVID-19 survivor reports that they have been diagnosed with brain fog or mild cognitive impairment (BF/MCI), or these terms appear in a medical report, hearing care professionals should be aware that many of the BF/MCI symptoms are very similar to those seen in patients with (central) auditory processing disorder. This article by audiologist Robert DiSogra, AuD, reviews the research on this subject and provides recommendations.
Read More